Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 70934-420 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
022dc727 c077 4611 8a3d 967ee99f9828 01
022dc727 c077 4611 8a3d 967ee99f9828 02
This is a graph showing the cumulative rates for time to first seizure between two groups of patients. The first group consisted of 234 patients taking 50mg/day of topiramate, while the second group consisted of 236 patients taking 400mg/day of topiramate. The graph plots the time (in days) on the x-axis and the cumulative rate on the y-axis.*
022dc727 c077 4611 8a3d 967ee99f9828 03
The text describes the change from baseline for the average monthly migraine period rate for patients who were administered Topamax in the double-blind phase. The dosage for Topamax varied between 100mg/day and 200mg/day. The statistical significance of this change is also mentioned in terms of p-values.*
70934 420 30 Master Bottle Label Approval Rev A 08 19
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.